Form Type: 4

SEC EDGAR Link
Acccession Number:0000899243-19-016723
Date:2019-06-10
Issuer: AMEDISYS INC (AMED)
Original Submission Date:

Reporting Person:

GINN SCOTT G
3854 AMERICAN WAY, SUITE A
BATON ROUGE, LA 70816

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2019-06-10 S 4,872 d $118.50 18,554 direct
COMMON STOCK 0 $0.00 2,654 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $118.26 to $118.87, inclusive. the reporting person undertakes to provide to amedisys, inc. (the "issuer"), any security holder of the issuer, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this form 4.
f2 the total amount of shares beneficially owned includes 887 shares held in an employee stock purchase plan account.
f3 the information in this report is based on a plan statement dated as of march 31, 2019.

Elevate your investments